233 related articles for article (PubMed ID: 34336882)
1. A Novel RNA-Binding Protein Signature to Predict Clinical Outcomes and Guide Clinical Therapy in Gastric Cancer.
Qiu Z; Jiang H; Ju K; Liu X
Front Med (Lausanne); 2021; 8():670141. PubMed ID: 34336882
[No Abstract] [Full Text] [Related]
2. Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer.
Qiu F; Zhu Y; Shi Y; Ji J; Jin Y
Dis Markers; 2021; 2021():4251763. PubMed ID: 34804261
[TBL] [Abstract][Full Text] [Related]
3. A Ferroptosis-Related Signature Robustly Predicts Clinical Outcomes and Associates With Immune Microenvironment for Thyroid Cancer.
Ge M; Niu J; Hu P; Tong A; Dai Y; Xu F; Li F
Front Med (Lausanne); 2021; 8():637743. PubMed ID: 33928101
[No Abstract] [Full Text] [Related]
4. A Novel RNA-Binding Protein-Based Nomogram for Predicting Survival of Patients with Gastric Cancer.
Zhu M; Cai J; Wu Y; Wu X; Feng L; Yin Z
Med Sci Monit; 2021 Jan; 27():e928195. PubMed ID: 33471782
[TBL] [Abstract][Full Text] [Related]
5. A Novel Model of Tumor-Infiltrating B Lymphocyte Specific RNA-Binding Protein-Related Genes With Potential Prognostic Value and Therapeutic Targets in Multiple Myeloma.
Zhang J; He P; Wang X; Wei S; Ma L; Zhao J
Front Genet; 2021; 12():778715. PubMed ID: 34976013
[No Abstract] [Full Text] [Related]
6. Systematic Analysis Identifies a Specific RNA-Binding Protein-Related Gene Model for Prognostication and Risk-Adjustment in HBV-Related Hepatocellular Carcinoma.
Li M; Liu Z; Wang J; Liu H; Gong H; Li S; Jia M; Mao Q
Front Genet; 2021; 12():707305. PubMed ID: 34422009
[TBL] [Abstract][Full Text] [Related]
7. Development and Verification of a Hypoxic Gene Signature for Predicting Prognosis, Immune Microenvironment, and Chemosensitivity for Osteosarcoma.
Wu F; Xu J; Jin M; Jiang X; Li J; Li X; Chen Z; Nie J; Meng Z; Wang G
Front Mol Biosci; 2021; 8():705148. PubMed ID: 35071320
[No Abstract] [Full Text] [Related]
8. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
9. Development and Multi-Data Set Verification of an RNA Binding Protein Signature for Prognosis Prediction in Glioma.
Sheng C; Chen Z; Lei J; Zhu J; Song S
Front Med (Lausanne); 2021; 8():637803. PubMed ID: 33634155
[No Abstract] [Full Text] [Related]
10. Systematic establishment and verification of an epithelial-mesenchymal transition gene signature for predicting prognosis of oral squamous cell carcinoma.
Ai J; Tan Y; Liu B; Song Y; Wang Y; Xia X; Fu Q
Front Genet; 2023; 14():1113137. PubMed ID: 37636263
[No Abstract] [Full Text] [Related]
11. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Immune-Stromal Score-Based Gene Signature and Molecular Subtypes in Osteosarcoma: Implications for Prognosis and Tumor Immune Microenvironment.
Zheng D; Yang K; Chen X; Li Y; Chen Y
Front Genet; 2021; 12():699385. PubMed ID: 34630511
[No Abstract] [Full Text] [Related]
13. A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.
Tu Z; Shu L; Li J; Wu L; Tao C; Ye M; Zhu X; Huang K
Front Cell Dev Biol; 2020; 8():588368. PubMed ID: 33634092
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer.
Liu Y; Wu J; Huang W; Weng S; Wang B; Chen Y; Wang H
J Transl Med; 2020 May; 18(1):201. PubMed ID: 32410620
[TBL] [Abstract][Full Text] [Related]
15. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients.
Xu X; Lu Y; Wu Y; Wang M; Wang X; Wang H; Chen B; Li Y
Cancer Cell Int; 2021 Feb; 21(1):117. PubMed ID: 33602220
[TBL] [Abstract][Full Text] [Related]
16. Stromal-Immune Score-Based Gene Signature: A Prognosis Stratification Tool in Gastric Cancer.
Wang H; Wu X; Chen Y
Front Oncol; 2019; 9():1212. PubMed ID: 31781506
[No Abstract] [Full Text] [Related]
17. Predicting the Clinical Outcome of Lung Adenocarcinoma Using a Novel Gene Pair Signature Related to RNA-Binding Protein.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li J; Xiao Y
Biomed Res Int; 2020; 2020():8896511. PubMed ID: 33195699
[TBL] [Abstract][Full Text] [Related]
18. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
[No Abstract] [Full Text] [Related]
19. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
Zou X; Hu Z; Huang C; Chang J
Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Prognostic Signature Model with Tumor Microenvironment for predicting Disease-free Survival after Radical Prostatectomy.
Zhao H; Zhang X; Shi Z; Guo B; Zhang W; He K; Hu X; Shi S
J Cancer; 2021; 12(8):2371-2384. PubMed ID: 33758613
[No Abstract] [Full Text] [Related]
[Next] [New Search]